MELANY MURRAY: Open Payments
NPI 1184192346 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 86 payments from 21 companies in 2025. Trend: 2023 $976 · 2024 $1,465 · 2025 $1,805
Food & beverage: $1,677Education: $128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $477 |
| Astellas Pharma US Inc | 5 | $231 |
| AstraZeneca Pharmaceuticals LP | 3 | $206 |
| PFIZER INC. | 12 | $178 |
| Novo Nordisk Inc | 8 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Tonix Medicines, Inc. | 2 | $53 |
| Axsome Therapeutics, Inc. | 3 | $49 |
Products named: VRAYLAR, BREZTRI, QULIPTA, NURTEC ODT, Veozah, REXULTI, CAPLYTA, Wegovy.
Industry payments across NE — which companies pay providers there.
